TCT 591: Preclinical Evaluation of a Novel Bioresorbable Sirolimus Eluting Magnesium-Alloy Scaffold in a Healthy Swine Coronary Arteries up to 540 Days
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Grant Support/Research Contract - Boston Scientific Corporation